Evaluating alcohol use in patients with alcoholic liver disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate alcohol recidivism in patients diagnosed with alcoholic liver disease, including acute alcoholic hepatitis and alcoholic cirrhosis. Adult subjects presenting at Weill Cornell Medical Center or Columbia University Medical Center will be invited to participate. The study involves a baseline survey followed by multiple follow-up assessments over a period of up to 10 years, which will include chart reviews and interviews to track alcohol use patterns. Clinical providers will remain blinded to the survey results to ensure unbiased data collection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* alcoholic liver disease able to consent

Exclusion Criteria:

* without alcoholic liver disease unable to consent

Where it's running

• New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Robert S Brown, MD, MPH — New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center
• Study coordinator: Nicole T Shen, MD
• Email: nts9004@nyp.org
• Phone: 3146095911

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exploring the role of gut bacteria in alcoholic hepatitis

  This study is trying to see how gut bacteria affect liver damage in people with severe alcoholic hepatitis to find new ways to help them feel better.

  Recruiting Hospices Civils de Lyon · Lyon · NCT06307964

• Cohort study on the impact of gut microbiome in alcoholic liver disease

  This study is trying to see how the gut bacteria of heavy drinkers affects the development and worsening of alcoholic liver disease.

  Recruiting Assistance Publique - Hôpitaux de Paris · Clamart, Île-de-France Region · NCT05895890

• Evaluating liver disease screening for individuals with alcohol use disorder

  This study tests if screening for liver disease with a special measurement helps people in alcohol treatment stay sober or drink less over six months.

  Recruiting at 2 sites Zealand University Hospital · Køge and 1 other locations · NCT05855031

• HMB supplementation for patients with alcoholic liver disease and COVID-19

  This study is testing if HMB supplements can help people with alcoholic liver disease who also have COVID-19 feel better and recover more effectively.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT04858412

• Improving early diagnosis of liver disease using integrated diagnostics

  This study is trying to improve how quickly and accurately liver disease is diagnosed by combining different tests and information from around 750 patients who are at risk or have abnormal liver blood tests.

  Recruiting Manchester University NHS Foundation Trust · Manchester, Greater Manchester · NCT04666402

• Understanding Alcohol-related Liver Disease in Europe

  This study looks at how alcohol-related liver disease develops in heavy drinkers to see if non-invasive tests can help identify those at risk of serious liver damage.

  Recruiting University Hospital, Lille · Lille · NCT04400604

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.